RIGL today
$45.69+$1.17 (+2.63%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bullish
1 hourSymmetric Triangle
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns down below $24.84
Key levels
Resistance$52.60
Resistance$49.70
Support$45.48
Support$37.60
Latest news & SEC filings
AnalystCitigroup keeps Buy rating on Rigel Pharmaceuticals, lifts price target
AnalystCitigroup keeps Buy rating on Rigel Pharmaceuticals, lifts target to $86
All RIGL news →About Rigel Pharmaceuticals
Rigel Pharmaceuticals is a biotechnology company that develops and sells therapies for blood disorders and cancer. Its approved medicines include TAVALISSE for chronic immune thrombocytopenia, REZLIDHIA for a type of acute myeloid leukemia with an IDH1 mutation, and GAVRETO for RET fusion-positive lung and thyroid cancers. The company also runs clinical programs for myelodysplastic syndrome and other conditions, working with partners such as Eli Lilly and MD Anderson. It sells products in the United States and, through partners, in Europe, Japan, Korea, Canada, and Israel.
Based on the company's 10-K filed Mar 3, 2026.
Nasdaq · Healthcare
RIGEL PHARMACEUTICALS INC (RIGL)
What Is the Price Target for RIGL?
SEPT Low Target
$49.00
SEPT Mid Target
$83.00
SEPT High Target
$85.00
Analyst Consensus
$83.00
Is RIGL a Buy or Sell Right Now?
Thesis
- •Revenue growing 64.2% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RIGL.
Start Free Trial →Is RIGL Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$75.60
47
Moat Score
NARROW
5/9
Piotroski Score
3.7
Altman Z-Score
What Is Smart Money Doing with RIGL?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Schorno Dean L | officer | Buy | 1,200 | $22K | Jun 1, 2026 |
| Schorno Dean L | officer | Buy | 2,181 | $28K | Jun 1, 2026 |
| Schorno Dean L | officer | Sale | 928 | $28K | Jun 1, 2026 |
| Santos David A | officer | Sale | 874 | $26K | Jun 1, 2026 |
| Rojkjaer Lisa | officer | Sale | 850 | $25K | Jun 1, 2026 |
| RODRIGUEZ RAUL R | director officer | Sale | 2,424 | $72K | Jun 1, 2026 |
| Furey Raymond J. | officer | Sale | 877 | $26K | Jun 1, 2026 |
| Ali-Jackson Kamil | director | Sale | 2,500 | $73K | May 26, 2026 |
| Wasman Jane | director | Buy | 5,750 | - | May 15, 2026 |
| MOOS WALTER H | director | Buy | 5,750 | - | May 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RIGL Growth Story
Revenue YoY
64.2%
3yr Revenue CAGR
34.8%
EPS Growth YoY
1867.68%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for RIGL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RIGL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:24:44 | $45.69 | 44,700 | $$2.0M | BUY |
| 22:00:14 | $46.00 | 1,069 | $$49K | BUY |
| 19:10:28 | $45.33 | 1,500 | $$68K | SELL |
| 17:10:42 | $44.88 | 1,000 | $$45K | SELL |
| 15:39:22 | $43.98 | 1,000 | $$44K | BUY |
5 dark pool trades shown · $$2.2M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for RIGL
PREVIEWSEPT Investing provides real-time options flow tracking for RIGL, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $45 | Nov 20 | 8 | $$370 | 2 | SWEEP |
| CALL | $50 | Nov 20 | 8 | $$50 | 2 | SWEEP |
| CALL | $45 | Nov 20 | 8 | $$380 | 2 | SWEEP |
| CALL | $50 | Nov 20 | 8 | $$60 | 2 | SWEEP |
| CALL | $45 | Nov 20 | 8 | $$380 | 2 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for RIGEL PHARMACEUTICALS INC (RIGL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RIGL — frequently asked questions
What is RIGL stock price today?
RIGEL PHARMACEUTICALS INC (RIGL) is at $45.69, up 2.63% (+$1.17) at the Nov 12, 2026 close.
Why is RIGL stock moving today?
Latest RIGL news — Nov 9, 2026: Citigroup keeps Buy rating on Rigel Pharmaceuticals, lifts price target · Nov 9, 2026: Citigroup keeps Buy rating on Rigel Pharmaceuticals, lifts target to $86
What is the RIGL price target?
The average analyst price target for RIGL is $83.00, ranging from $49 to $85, based on 4 analysts.
What do analysts rate RIGL?
Analyst ratings for RIGL: 0 Buy, 7 Hold, 0 Sell — consensus Hold.
Did RIGL beat earnings?
RIGL last reported on Nov 5, 2026: EPS $0.65 vs $0.92 expected — a miss of 29.4%.
What is RIGL's P/E ratio?
RIGL trades at a P/E of 3.0 vs a Healthcare average of 18.5.
Does RIGL pay a dividend?
RIGL does not currently pay a dividend.
What are RIGL support and resistance levels?
Support: $45.48, $37.60, $35.01. Resistance: $49.70, $52.60.
What are insiders doing with RIGL?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on RIGL?
Nov 9, 2026: Citigroup keeps Buy rating on Rigel Pharmaceuticals, lifts price target · Nov 9, 2026: Citigroup keeps Buy rating on Rigel Pharmaceuticals, lifts target to $86